MRD Monitoring in Acute Lymphoblastic Leukemia
0 Visualizzazioni
• 06/15/23
0
0
Incorporare
administrator
Iscritti
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti